# Predictive Factors for COVID-19 in Rheumatology

> **NCT04567576** · — · UNKNOWN · sponsor: **Fundación Santa Fe de Bogota** · enrollment: 150 (estimated)

## Conditions studied

- Rheumatic Diseases
- Covid19

## Interventions

- **DRUG:** Disease-modifying antirheumatic drugs (DMARDs)

## Key facts

- **NCT ID:** NCT04567576
- **Lead sponsor:** Fundación Santa Fe de Bogota
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-10
- **Primary completion:** 2021-05
- **Final completion:** 2021-10-31
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2020-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04567576

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04567576, "Predictive Factors for COVID-19 in Rheumatology". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04567576. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*